StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
4
Publishing Date
2022 - 05 - 04
1
2021 - 12 - 10
1
2021 - 12 - 08
1
2021 - 11 - 12
1
Sector
Health technology
4
Tags
Agreement
8
Alzheimer's
10
America
67
Antibody
8
Application
8
Approval
13
Biosimilar
32
Breast
13
Business
9
Cancer
91
Cell
9
Chmp
10
Diabetes
15
Diagnostics
17
Disease
61
Drug
85
Earnings
18
Europe
15
Expansion
10
Expected
35
Eye
15
Fda
22
Financial
24
Global
228
Growing
43
Growth
235
Health
19
Immunotherapy
11
Infection
9
Kisqali
11
Leukemia
10
Liver
11
Market
592
N/a
945
Novartis
132
People
13
Pharma
13
Pharmaceuticals
17
Pipeline
12
Positive
15
Potential
10
Reach
34
Report
194
Research
118
Respiratory
11
Results
38
Risk
10
Sales
9
Sclerosis
13
Set
15
Study
15
T-cell
11
Technology
12
Therapeutics
109
Therapy
64
Treatment
113
Trial
16
Update
10
Vaccine
10
Year
12
Entities
Eli lilly and company
1
Novartis ag
4
Symbols
A
3
AMAM
2
ANIX
4
ARAY
4
ARVN
2
ATNX
5
ATOS
4
AZN
13
AZNCF
2
BCTX
10
BIOC
4
BMY
3
BYSI
2
CELC
5
CNTX
3
DGX
2
EXAS
4
FNCTF
4
GE
2
GENE
2
GILD
22
GLAXF
3
GLSI
6
GNPX
2
GSK
3
GTHX
5
HOLX
8
ICAD
4
ICCM
2
IMMP
5
IMV
2
INCY
4
INFI
4
INMB
2
INTS
3
JAGX
4
LLY
7
MACK
2
MDT
2
MGNX
2
MRK
7
MYGN
9
NSTG
2
NTRA
3
NVS
9
NVSEF
4
NVTA
2
OCX
2
OLMA
2
ONCY
9
PBYI
5
PFE
6
PHG
3
RDUS
2
SGEN
4
SNY
6
SNYNF
4
SRNE
2
THER
2
VERU
11
Exchanges
Nasdaq
4
Nyse
4
Crawled Date
2022 - 05 - 04
1
2021 - 12 - 10
1
2021 - 12 - 08
1
2021 - 11 - 12
1
Crawled Time
08:00
1
11:00
1
13:00
1
15:00
1
Source
www.globenewswire.com
3
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Breast cancer
symbols :
NVSEF
save search
New Novartis data demonstrate only Kisqali® offers more life in the first-line setting for postmenopausal HR+/HER2- advanced breast cancer patients
Published:
2022-05-04
(Crawled : 08:00)
- globenewswire.com
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
6.3%
|
O:
-0.1%
H:
0.0%
C:
0.0%
kisqali
novartis
cancer
breast cancer
her2-
her2
Novartis data highlight efficacy of Piqray® in HR+/HER2- metastatic breast cancer with a PIK3CA driver mutation immediately post-CDK4/6i
Published:
2021-12-10
(Crawled : 13:00)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
15.29%
|
O:
-1.81%
H:
0.0%
C:
-0.31%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
15.08%
|
O:
-0.49%
H:
0.0%
C:
0.0%
piqray
novartis
media
cancer
breast cancer
her2-
her2
metastatic breast cancer
New Kisqali® data shows consistent overall survival benefit across genomic and clinical subtypes of interest in HR+/HER2- metastatic breast cancer
Published:
2021-12-08
(Crawled : 15:00)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
17.37%
|
O:
1.8%
H:
0.0%
C:
0.0%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
15.37%
|
O:
1.04%
H:
0.0%
C:
0.0%
kisqali
genomic
cancer
breast cancer
her2-
her2
metastatic breast cancer
Breast Cancer Drugs Global Market Report 2021
Published:
2021-11-12
(Crawled : 11:00)
- prnewswire.com
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
12.21%
|
O:
-0.3%
H:
0.0%
C:
0.0%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
185.43%
|
O:
-0.49%
H:
0.0%
C:
0.0%
cancer drug
cancer
drug
breast cancer
market
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
News
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
News
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.